Boostrix Generic Name & Formulations
Single-dose vials or prefilled syringes (without needles)—10
Diphtheria, tetanus, and pertussis booster immunization in patients ≥10 years of age. Immunization during the 3rd trimester of pregnancy to prevent pertussis in infants <2 months of age.
Boostrix Dosage and Administration
Adults and Children
Booster immunization: <10yrs: not recommended. ≥10yrs (≥5yrs after last childhood DTwP or DTaP or adult Td vaccine): 0.5mL IM once into deltoid muscle. Immunization during 3rd trimester of pregnancy: 0.5mL IM once into deltoid muscle.
Boostrix Boxed Warnings
Guillain-Barre syndrome (within 6 weeks) after previous tetanus toxoid vaccine: see full labeling. Progressive or unstable neurologic disorders (eg, cerebrovascular events, acute encephalopathic conditions). Previous Arthus-type hypersensitivity reaction: not recommended until ≥10yrs after prior dose of tetanus toxoid-containing vaccine. Immunosuppressed. Have epinephrine available. Latex allergy. Pregnancy: see full labeling. Nursing mothers.
Concomitant vaccines: see full labeling. Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may get suboptimal response.
Boostrix Adverse Reactions
Local reactions (eg, pain, redness, swelling), fever, headache, fatigue, GI upset.
Boostrix Clinical Trials
Boostrix Patient Counseling